J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dykhuizen, M.
Right arrow Articles by Pauza, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dykhuizen, M.
Right arrow Articles by Pauza, C. D.
Agricola
Right arrow Articles by Dykhuizen, M.
Right arrow Articles by Pauza, C. D.

Journal of General Virology, Vol 79, 2461-2467, Copyright © 1998 by Society for General Microbiology


ARTICLES

Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression

M Dykhuizen, JL Mitchen, DC Montefiori, J Thomson, L Acker, H Lardy and CD Pauza
Wisconsin Regional Primate Research Center, University of Wisconsin, Madison 53715, USA.

Clinical and laboratory markers of simian immunodeficiency virus (SIV) infection were studied during the first 3 months after intravenous inoculation of rhesus macaques. Virus-binding serum antibody titres were correlated strongly with disease progression (P < 0.005) and were predictive of disease outcome by 7 weeks after inoculation. Low virus- binding serum antibody responses to SIV occurred in animals that also showed acute depletion of circulating CD20+ B cells. Acute damage to the CD4+ T cell and CD20+ B cell populations rendered some animals incapable of mounting virus-specific antibody responses and these macaques became the rapidly progressing cases comprising approximately 20-30% of infected animal cohorts.


This article has been cited by other articles:


Home page
J. Virol.Home page
E. Ryzhova, P. Aye, T. Harvey, W. Cao, A. Lackner, and F. Gonzalez-Scarano
Intrathecal Humoral Responses Are Inversely Associated with the Frequency of Simian Immunodeficiency Virus Macrophage-Tropic Variants in the Central Nervous System
J. Virol., August 15, 2009; 83(16): 8282 - 8288.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. J. Bissel, G. Wang, D. Bonneh-Barkay, A. Starkey, A. M. Trichel, M. Murphey-Corb, and C. A. Wiley
Systemic and Brain Macrophage Infections in Relation to the Development of Simian Immunodeficiency Virus Encephalitis
J. Virol., May 15, 2008; 82(10): 5031 - 5042.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. J. Miller, M. Genesca, K. Abel, D. Montefiori, D. Forthal, K. Bost, J. Li, D. Favre, and J. M. McCune
Antiviral Antibodies Are Necessary for Control of Simian Immunodeficiency Virus Replication
J. Virol., May 15, 2007; 81(10): 5024 - 5035.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
Q. Wei, J. W. Stallworth, P. J. Vance, J. A. Hoxie, and P. N. Fultz
Simian Immunodeficiency Virus (SIV)/Immunoglobulin G Immune Complexes in SIV-Infected Macaques Block Detection of CD16 but Not Cytolytic Activity of Natural Killer Cells.
Clin. Vaccine Immunol., July 1, 2006; 13(7): 768 - 778.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L. J. Picker, S. I. Hagen, R. Lum, E. F. Reed-Inderbitzin, L. M. Daly, A. W. Sylwester, J. M. Walker, D. C. Siess, M. Piatak Jr., C. Wang, et al.
Insufficient Production and Tissue Delivery of CD4+ Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection
J. Exp. Med., November 15, 2004; 200(10): 1299 - 1314.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Sugimoto, K. Tadakuma, I. Otani, T. Moritoyo, H. Akari, F. Ono, Y. Yoshikawa, T. Sata, S. Izumo, and K. Mori
nef Gene Is Required for Robust Productive Infection by Simian Immunodeficiency Virus of T-Cell-Rich Paracortex in Lymph Nodes
J. Virol., April 1, 2003; 77(7): 4169 - 4180.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z.-Q. Zhang, T.-M. Fu, D. R. Casimiro, M.-E. Davies, X. Liang, W. A. Schleif, L. Handt, L. Tussey, M. Chen, A. Tang, et al.
Mamu-A*01 Allele-Mediated Attenuation of Disease Progression in Simian-Human Immunodeficiency Virus Infection
J. Virol., November 18, 2002; 76(24): 12845 - 12854.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. L. Seman, W. F. Pewen, L. F. Fresh, L. N. Martin, and M. Murphey-Corb
The replicative capacity of rhesus macaque peripheral blood mononuclear cells for simian immunodeficiency virus in vitro is predictive of the rate of progression to AIDS in vivo
J. Gen. Virol., October 1, 2000; 81(10): 2441 - 2449.
[Abstract] [Full Text]


Home page
Vet PatholHome page
L. A. Obert and E. A. Hoover
Relationship of Lymphoid Lesions to Disease Course in Mucosal Feline Immunodeficiency Virus Type C Infection
Vet. Pathol., September 1, 2000; 37(5): 386 - 401.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. T. Evans, P. Jing, T. M. Allen, D. H. O'Connor, H. Horton, J. E. Venham, M. Piekarczyk, J. Dzuris, M. Dykhuzen, J. Mitchen, et al.
Definition of Five New Simian Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitopes and Their Restricting Major Histocompatibility Complex Class I Molecules: Evidence for an Influence on Disease Progression
J. Virol., August 15, 2000; 74(16): 7400 - 7410.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
L. Holterman, H. Niphuis, W. Koornstra, R. Dubbes, P. ten Haaft, and J. L. Heeney
The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques
J. Gen. Virol., July 1, 2000; 81(7): 1719 - 1726.
[Abstract] [Full Text]


Home page
J. Virol.Home page
L. D. Giavedoni, M. C. Velasquillo, L. M. Parodi, G. B. Hubbard, and V. L. Hodara
Cytokine Expression, Natural Killer Cell Activation, and Phenotypic Changes in Lymphoid Cells from Rhesus Macaques during Acute Infection with Pathogenic Simian Immunodeficiency Virus
J. Virol., February 15, 2000; 74(4): 1648 - 1657.
[Abstract] [Full Text]


Home page
J. Virol.Home page
C. Yin, M. S. Wu, C. D. Pauza, and M. S. Salvato
High Major Histocompatibility Complex-Unrestricted Lysis of Simian Immunodeficiency Virus Envelope-Expressing Cells Predisposes Macaques to Rapid AIDS Progression
J. Virol., May 1, 1999; 73(5): 3692 - 3701.
[Abstract] [Full Text]


Home page
J. Virol.Home page
K. K. Steger, P. M. Waterman, and C. D. Pauza
Acute Effects of Pathogenic Simian-Human Immunodeficiency Virus Challenge on Vaccine-Induced Cellular and Humoral Immune Responses to Gag in Rhesus Macaques
J. Virol., March 1, 1999; 73(3): 1853 - 1859.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1998 by the Society for General Microbiology.